Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Personalizing Post Surgical Thromboprophylaxis for Patients With Peripheral Artery Disease
NCT07613840Recruiting
- Sponsor
- Massachusetts General Hospital
- Start
- Apr 2025
- Primary completion
- Apr 2027
- Countries
- 1
01
Overview
Randomised, open-label trial in peripheral artery disease (PAD) (2 arms), sponsored by Massachusetts General Hospital. Primary endpoint: Incidence of Arterial Thrombosis in the Treated Limb at 12 months. Started Apr 2025; status: recruiting.
02
Conditions
peripheral artery disease (PAD)
Beyond the preview
Go deeper on NCT07613840.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07613840.